Skip to content
Lysosome
Underexploited Cellular Orchestrator
Lysosome – Disease Correlation
Platform
Promise of BXQ-350
BXQ-350 Anti Cancer Properties
BXQ-350 Mechanism of Action
Pipeline
Clinical Trials
CIPN
BXQ-350 Neuroprotective Outcomes
CIPN Market Opportunity
What is CIPN?
Impact of CIPN
Resources
Video Library
Abstracts
Posters
Case Studies
About Bexion
Leadership
Key Milestones
Media & Press
Contact
Comprehensive Investor Presentation
Your browser does not support the video tag
Learn more about Bexion Pharmaceuticals through our comprehensive video presentation
Other Videos
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Immunostimulating Properties of BXQ-350
Tolerability and Preliminary Efficacy of BXQ-350 for Solid Tumors and Gliomas: First-in-human, first-in-class phase 1 trial
Bexion Pharmaceuticals Corporate Video
Bexion Highlight Reel
Alpha Summit Presentation
3rd Annual Glioblastoma Drug Development Presentation
Advancements TV Series presentation
UCSF Awards Video
BIO CEO and Investor Presentation
Bexion Investment Opportunity Presentation
Dr. Rixe Video – BXQ-350 MOA
